发布求助
文献互助 智能选刊 最新文献

Clinical Diabetes最新文献

筛选
英文 中文
Goodbye and Be Well. 再见，祝身体健康。
Clinical Diabetes Pub Date : 2025-12-15 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0071
Stephen A Brunton
{"title":"Goodbye and Be Well.","authors":"Stephen A Brunton","doi":"10.2337/cd25-0071","DOIUrl":"https://doi.org/10.2337/cd25-0071","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"636"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Appreciation of Our Journal and Its Extended Family. 感谢我们的期刊和它的大家庭。
Clinical Diabetes Pub Date : 2025-12-15 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-dk05
Debbie Kendall
{"title":"In Appreciation of Our Journal and Its Extended Family.","authors":"Debbie Kendall","doi":"10.2337/cd25-dk05","DOIUrl":"https://doi.org/10.2337/cd25-dk05","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"637"},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the Effects of Ganoderma lucidum and Kombucha Mushrooms on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. 比较灵芝和康普茶蘑菇对2型糖尿病患者血糖控制的作用：一项随机临床试验。
Clinical Diabetes Pub Date : 2025-10-27 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0032
Leili Yekefallah, Fatemeh Aghakhanbeigi, Azadeh Jalalpour, Peyman Namdar, Mohamad Hossein Mafi
{"title":"Comparing the Effects of <i>Ganoderma lucidum</i> and Kombucha Mushrooms on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.","authors":"Leili Yekefallah, Fatemeh Aghakhanbeigi, Azadeh Jalalpour, Peyman Namdar, Mohamad Hossein Mafi","doi":"10.2337/cd25-0032","DOIUrl":"10.2337/cd25-0032","url":null,"abstract":"<p><p>This randomized clinical trial compared the effects of <i>Ganoderma lucidum</i> and kombucha mushrooms on glycemic control in patients with type 2 diabetes. After the intervention, there were significant differences among the <i>G. lucidum</i>, kombucha mushroom, and control groups in fasting blood glucose, 2-hour postprandial glucose, and A1C. In the <i>G. lucidum</i> and kombucha mushroom groups, these measures all decreased significantly from baseline to after the intervention. The use of both <i>G. lucidum</i> and kombucha mushrooms was effective in glycemic control, and there was no significant difference in effectiveness between the two. Further studies of different doses and longer follow-up periods may clarify the best use of these substances.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"813-822"},"PeriodicalIF":0.0,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Vitamin B1-6-12 Supplementation Compared With Vitamin B12 and Gabapentin in Patients With Diabetic Peripheral Neuropathy. 补充维生素B1-6-12与维生素B12和加巴喷丁治疗糖尿病周围神经病变的疗效比较
Clinical Diabetes Pub Date : 2025-10-23 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0039
Nattawat Poolsawatkitikool
{"title":"Effectiveness of Vitamin B1-6-12 Supplementation Compared With Vitamin B12 and Gabapentin in Patients With Diabetic Peripheral Neuropathy.","authors":"Nattawat Poolsawatkitikool","doi":"10.2337/cd25-0039","DOIUrl":"10.2337/cd25-0039","url":null,"abstract":"<p><p>The use of gabapentin, a first-line drug for diabetic peripheral neuropathy (DPN), is limited by its side effects, leading to more frequent use of vitamin B as an alternative. This randomized controlled trial of 237 patients with diabetes and at least probable DPN assessed pain outcomes using the Revised Thai Short-Form McGill Pain Questionnaire, Visual Analog Scale, Present Pain Intensity, and monofilament risk score at baseline and 4 and 12 weeks. Gabapentin showed superior improvement across all measures compared with vitamin B1-6-12 and B12, supporting its role as first-line therapy. However, vitamin B1-6-12 remains a cost-effective alternative with lower side effect, warranting further economic evaluation.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"794-804"},"PeriodicalIF":0.0,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Medication Adherence and Medication Optimization With a Medicaid-Funded Statewide Diabetes Quality Improvement Project. 通过医疗补助资助的全州糖尿病质量改善项目改善药物依从性和药物优化。
Clinical Diabetes Pub Date : 2025-10-23 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0025
Elizabeth A Beverly, Anirudh Prabu, Joshua J Joseph, Douglas Einstadter, Jordan Fiegl, Thomas E Love, Katherine Jenkins, Allison Lorenz, Shah Jalal Uddin, Michael W Konstan, Mary S Applegate, Shari D Bolen, Kathleen M Dungan
{"title":"Improving Medication Adherence and Medication Optimization With a Medicaid-Funded Statewide Diabetes Quality Improvement Project.","authors":"Elizabeth A Beverly, Anirudh Prabu, Joshua J Joseph, Douglas Einstadter, Jordan Fiegl, Thomas E Love, Katherine Jenkins, Allison Lorenz, Shah Jalal Uddin, Michael W Konstan, Mary S Applegate, Shari D Bolen, Kathleen M Dungan","doi":"10.2337/cd25-0025","DOIUrl":"10.2337/cd25-0025","url":null,"abstract":"<p><p>Medication adherence is a barrier to achieving glycemic goals among Medicaid recipients with diabetes. The Diabetes Quality Improvement Program Collaborative recruited 19 primary care practices serving a high volume of Medicaid patients in Ohio with the goal of reducing the percentage of adults with type 2 diabetes with A1C >9.0% through a 1-year intervention. The mean medication possession ratio (MPR) improved from 71.6% during the pre-intervention period to 74.1% at year 1 post-intervention-a relative improvement of 3.4%. Factors associated with a lower MPR included younger age, identifying as non-Hispanic Black or Hispanic, and a pre-intervention A1C >9.0%. Although the initiative modestly improved medication adherence, addressing persistent disparities and expanding prescribing of therapies with cardiorenal benefits will be necessary to improve diabetes outcomes in the Medicaid population.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"823-832"},"PeriodicalIF":0.0,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pathway to Type 2 Diabetes Remission: Weight Reduction and A1C Improvements Are Facilitated by a Low-Calorie Diet Including Diabetes-Specific Nutritional Formula and the Use of Digitally Enabled Reinforcement. 通往2型糖尿病缓解的途径：低热量饮食，包括糖尿病特定营养配方和使用数字化强化，有助于减轻体重和改善糖化血红蛋白。
Clinical Diabetes Pub Date : 2025-10-16 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0054
Michael Trenell, Maria Camprubi Robles, Louise Taylor, Nicky Northway, Kirk W Kerr, Carl Lumsden, Leah Avery, David Faluyi, Ricardo Rueda, Suela Sulo
{"title":"A Pathway to Type 2 Diabetes Remission: Weight Reduction and A1C Improvements Are Facilitated by a Low-Calorie Diet Including Diabetes-Specific Nutritional Formula and the Use of Digitally Enabled Reinforcement.","authors":"Michael Trenell, Maria Camprubi Robles, Louise Taylor, Nicky Northway, Kirk W Kerr, Carl Lumsden, Leah Avery, David Faluyi, Ricardo Rueda, Suela Sulo","doi":"10.2337/cd25-0054","DOIUrl":"10.2337/cd25-0054","url":null,"abstract":"<p><p>This article reports on the feasibility and effectiveness of a 12-week program, including a low-calorie diet using a diabetes-specific nutritional formula meal replacement, a digitally enabled self-management app, and coaching, on measurable outcomes of weight, BMI, A1C levels, and blood pressure in adults with type 2 diabetes and excess body weight. Participation in the program reduced body weight by a mean 11 ± 6.5 kg, BMI by 3.7 ± 2.2 kg/m<sup>2</sup>, A1C by 1%, systolic blood pressure by 4.5 ± 16.1 mmHg, and diastolic blood pressure by 5.8 ± 16.9 mmHg (all <i>P</i> <0.01).</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"772-780"},"PeriodicalIF":0.0,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Equitable Management of Type 2 Diabetes in American Indian and Alaska Native Adults. 美国印第安人和阿拉斯加原住民成人2型糖尿病的公平管理。
Clinical Diabetes Pub Date : 2025-10-16 eCollection Date: 2025-05-01 DOI: 10.2337/cd25-0022
Brian G Collins, Cindy O Jean-Baptiste
{"title":"Equitable Management of Type 2 Diabetes in American Indian and Alaska Native Adults.","authors":"Brian G Collins, Cindy O Jean-Baptiste","doi":"10.2337/cd25-0022","DOIUrl":"10.2337/cd25-0022","url":null,"abstract":"<p><p>Prior to the 1940s, type 2 diabetes was considered a rare disease in American Indian and Alaska Native (AI/AN) individuals. However, because of multiple complex factors, it rapidly progressed and became endemic within a matter of decades. Despite community-led interventions to prevent diabetes onset and progression, AI/AN individuals are disproportionately affected by diabetes and remain grossly underrepresented in diabetes treatment research. To provide equitable health care for AI/ANs with diabetes, clinicians should develop an understanding of important socioeconomic and environmental factors that influence health outcomes.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 5","pages":"723-734"},"PeriodicalIF":0.0,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes Management: Evolution or Revolution? 糖尿病管理：进化还是革命？
Clinical Diabetes Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.2337/cd25-ed04
Stephen A Brunton
{"title":"Diabetes Management: Evolution or Revolution?","authors":"Stephen A Brunton","doi":"10.2337/cd25-ed04","DOIUrl":"https://doi.org/10.2337/cd25-ed04","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 4","pages":"460"},"PeriodicalIF":0.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12547070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Introduction to Your Rights and Care Standards: A Guide for People with Type 2 Diabetes. Clinical Diabetes 2025;43:334. 勘误：介绍您的权利和护理标准：2型糖尿病患者指南。临床糖尿病2025；43:334。
Clinical Diabetes Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.2337/cd25-er04
{"title":"Erratum: Introduction to Your Rights and Care Standards: A Guide for People with Type 2 Diabetes. Clinical Diabetes 2025;43:334.","authors":"","doi":"10.2337/cd25-er04","DOIUrl":"https://doi.org/10.2337/cd25-er04","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.2337/cd25-pint.].</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 4","pages":"632"},"PeriodicalIF":0.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Good To Know: Diabetes-Related Chronic Kidney Disease (CKD). 最好知道：糖尿病相关的慢性肾脏疾病（CKD）。
Clinical Diabetes Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.2337/cd25-pe04
{"title":"Good To Know: Diabetes-Related Chronic Kidney Disease (CKD).","authors":"","doi":"10.2337/cd25-pe04","DOIUrl":"https://doi.org/10.2337/cd25-pe04","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 4","pages":"631"},"PeriodicalIF":0.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12547047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书